Pharmafile Logo
Pharmafocus logo
Advanced Search

J&J’s Darzalex cuts risk of disease progression and death by 50%, new study shows

December 13, 2017
Research and Development Genmab, J&J, JJ, Janssen, Johnson & Johnson, darzalex, multiple myeloma, pharma

Johnson and Johnson has revealed data which demonstrates that Darzalex (daratumumab), when combined with a regimen of bortezomib, melphalan and …

News
teva_canada

Tumultuous times at Teva continue, with Chairman exit

December 13, 2017
Medical Communications, Research and Development Teva, biotech, drugs, pharma, pharmaceutical

In the latest addition to a number of high profile exits from Teva, previous interim Chief Executive and the company’s …

News
fdaoutsideweb

FDA approves first short-acting, follow-on biologic of Lilly’s Humalog insulin product

December 12, 2017
Manufacturing and Production, Sales and Marketing Admelog, FDA, Humalog, Sanofi, diabetes, insulin, pharma

The FDA has announced its approval of Sanofi’s Admelog (insulin lispro), the first follow-on biologic version of Eli Lilly’s Humalog …

News
money-2180330_960_720

Latest US company accused of price gouging, after 2,469% increase

December 12, 2017
Manufacturing and Production, Sales and Marketing Avondale Pharmaceutical, Niacor, biotech, drugs, pharma, pharmaceutical

It seems that no matter how much bad press comes their way, certain pharmaceutical companies are more than happy to …

News
shutterstock_212035546

Single, high-dose vaccine could provide better protection against cholera outbreaks, new research shows

December 12, 2017
Manufacturing and Production, Research and Development Africa, Asia, Caribbean, Cholera, Vaccine, paxvax, pharma

A team of researchers at the University of Maryland School of Medicine (UMSOM) has been assessing the effectiveness of a …

News
sanofi_new_paris_hq

Sanofi issues US-wide recall for arthritis product, after adverse events

December 12, 2017
Manufacturing and Production Sanofi, Synvisc-One, biotech, drugs, pharma, pharmaceutical

Sanofi has announced a recall of 12,380 syringes of its Synvisc-One product for the treatment of osteoarthritis, after it was …

News
brainss

Ionis scores huge breakthrough in Huntington’s, Roche licenses drug

December 12, 2017
Manufacturing and Production, Research and Development Ionis, Roche, biotech, drugs, pharma, pharmaceutical

Ionis Pharmaceuticals has revealed findings from its Phase 1/2a study into a treatment for Huntington’s disease and the strong data …

News

Exscientia appoints Oxford Innovation Sciences founder and ex-Lansdowne CEO as Deputy Chairman

December 11, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alex Snow, Exscientia, appointment

Exscientia, an Oxford-based drug design firm which has made headlines this year for its collaboration with GlaxoSmithKline to leverage its …

Appointment
hands-600497_960_720

To succeed in emerging market medicine, anticipation and innovation are essential

December 11, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abbott, biotech, drugs, emerging markets, pharma, pharmaceutical

Andrew Lane, Executive Vice President of Established Pharmaceuticals at Abbott, discusses the key steps to be taken when reaching out …

Feature

FDA issued the fewest warnings over pharma advertising this year since 1997

December 11, 2017
Sales and Marketing Amherst, FDA, advertising, cipher, orexigen, pharma

Throughout 2017, it has emerged that the FDA has issued a record low number of warning letters to pharmaceutical firms …

News
lilly_entrance_web

Cyramza fails to improve overall survival in gastric cancer, Lilly scraps regulatory plans

December 11, 2017
Research and Development, Sales and Marketing Cancer, Eli Lilly, cyramza, gastric cancer, pharma

Eli Lilly has unveiled Phase 3 results which reveal that its VEGF Receptor 2 antagonist Cyramza (ramucirumab) met its primary …

News
teva_small

Teva job cut rumours resurface, 10,000 expected

December 11, 2017
Manufacturing and Production, Sales and Marketing Teva, biotech, drugs, pharma, pharmaceutical

Only last month, the story broke that Teva was looking to cut away a number of employees, the rumours have …

News
shutterstock_274590824

PhRMA launches lawsuit against the state of California over anti-price hike bill

December 11, 2017
Sales and Marketing Drug pricing, PhRMA, california, pharma, price hikes

The state of California has become the target of legal action after the lobbying group Pharmaceutical Research and Manufacturers of …

News
nhs_parliament_2_4

NHS trust boss of major hospital hands in fiery resignation notice

December 11, 2017
Medical Communications, Sales and Marketing NHS, biotech, drugs, pharma, pharmaceutical

Bob Kerslake, now former chair of King’s College hospital, London, has handed in his resignation, citing the lack of long-term …

News
top_ten_1

Top Ten most popular articles on Pharmafile.com this week

December 8, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, most read news, pharma, pharmaceutical, top ten

Despite us nearing the end of the year, the news has not been slowing down at all. Headlines across Europe …

News
roche_close

Roche Tecentriq combo effective, but is it enough?

December 8, 2017
Medical Communications, Research and Development Roche, biotech, drugs, pharma, pharmaceutical, tecentriq

When Roche announced that its combination treatment of Tecentriq, alongside its own drug Avastin and chemotherapy, successfully extended progression-free survival …

News
gilead-sciences

Gilead makes $567m strategic acquisition for next-gen CAR-T

December 8, 2017
Medical Communications, Sales and Marketing CAR-T, Cell Design Labs, Gilead, Kite, biotech, drugs, pharma, pharmaceutical

It’s only four months since Gilead completed its buy-out of Kite Pharma for $11.9 billion, but it’s already moving quickly …

News
philippines-1195394_960_720

Philippines ups pressure on Sanofi over dengue vaccine

December 8, 2017
Medical Communications Sanofi, biotech, drugs, pharma, pharmaceutical

Since Sanofi released further data from a six-year study which showed that the risk of a severe dengue reaction is …

News
upwards_graph

Sage Therapeutics stock pops on depression P2 results

December 8, 2017
Medical Communications, Research and Development Sage Therapeutics, biotech, drugs, pharma, pharmaceutical

Sage Therapeutics’ stock rocketed after it announced that Phase 2 results for its treatment for major depressive disorder (MDD) were …

News
james-levine-11206608

Fondation Ipsen announces Dr James Levine as new President

December 7, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Fondation Ipsen has announced its appointment of Dr James A Levine as its new President. The organisation was set up …

Appointment
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026